Japanese Journal of Cancer and Chemotherapy
SJR0.118
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.118 | Q4 | 6.5% | |
| 2024 | — | — | 0.115 | Q4 | 9.0% | |
| 2023 | — | — | 0.117 | Q4 | 16.1% | |
| 2022 | — | — | 0.116 | Q4 | 19.6% | |
| 2021 | — | — | 0.115 | Q4 | 21.6% | |
| 2020 | — | — | 0.121 | Q4 | 10.8% | |
| 2019 | — | — | 0.116 | Q4 | 16.0% | |
| 2018 | — | — | 0.118 | Q4 | 6.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
0385-0684
region
Asiatic Region
coverage
1979-2025